Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2003
03/05/2003CN1399956A Sanjiao tablet preparation
03/05/2003CN1102407C Antidepressive capsule and preparing process thereof
03/05/2003CN1102406C Medicine for treating burn (scald) and preparation process
03/05/2003CN1102405C Chinese medicine composition for treating acyesis
03/05/2003CN1102403C Huanyang oral liquid
03/05/2003CN1102400C Prolifration treating bolus
03/05/2003CN1102399C Antilipemic blood circulation promoting xueluofu capsule
03/05/2003CN1102398C Eye ointment for curing myopia and its production process
03/05/2003CN1102394C Health care product containing lacteinand its preparing method
03/04/2003US6528699 Inserting nucleic acid construct which comprises promoter, milk protein specific signal sequence; can use for treating diabetes and multiple sclerosis
03/04/2003US6528307 Stable cloned T-lymphocyte cell line; use therapy, bioassay, drug screening, anticancer agent
03/04/2003US6528306 Engraftable human neural stem cells
03/04/2003US6528305 Method of producing infectious reovirus
03/04/2003US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications
03/04/2003US6528294 To effect protein phosphorylation; for use in diagnosis and therapy
03/04/2003US6528245 Bone marrow cells as a source of neurons for brain and spinal cord repair
03/04/2003US6528084 Composition and method
03/04/2003US6528062 Fermented solution of a mixture of extract from leaves of a ginkgo tree, extract from ganoderma, extract from bark of a chestnut tree, extract from acorns, extract from leaves of an evergreen oak tree, extract from bamboo, extract from leaves
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528057 Method for removal of HIV and other viruses from blood
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
03/04/2003US6528040 EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
03/04/2003US6527925 Contact assemblies, methods for making contact assemblies, and plating machines with contact assemblies for plating microelectronic workpieces
02/2003
02/27/2003WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003WO2003016540A2 Humanised baculovirus
02/27/2003WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes
02/27/2003WO2003016507A2 Generation of multipotent central nervous system stem cells
02/27/2003WO2003016499A2 Combinatorial methods for inducing cancer cell death
02/27/2003WO2003015850A1 Method for inducing selectively suppressed immune response
02/27/2003WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine
02/27/2003WO2003015803A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same
02/27/2003WO2003015802A1 Composition for treatment of articular cartilage damage
02/27/2003WO2003015800A1 Tissue implants and methods for making and using same
02/27/2003WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces
02/27/2003WO2003015756A1 Preparation of microparticles
02/27/2003WO2003015755A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
02/27/2003WO2003015724A1 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
02/27/2003WO2003015705A2 In situ immunization
02/27/2003WO2003015612A2 Materials and methods to promote repair of nerve tissue
02/27/2003WO2003015506A1 Propagation of human hepatoblastoma cell in non-human animals
02/27/2003WO2002102989A3 Method for neural stem cell differentiation using valproate
02/27/2003WO2002102988A3 Method for neural stem cell differentiation using 5ht-1a agonists
02/27/2003WO2002099037A3 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
02/27/2003WO2002098278A3 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
02/27/2003WO2002096471A3 Viral inactivation process using antioxidant
02/27/2003WO2002089746A3 Hematopoietic stem cell chimerism to treat autoimmune disease
02/27/2003WO2002087511A3 Modulators of elastase inhibitor secretion
02/27/2003WO2002086154A8 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
02/27/2003WO2002083864A3 Methods and reagents for cell transplantation
02/27/2003WO2002080851A3 Chimeric vaccines
02/27/2003WO2002067867A3 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
02/27/2003WO2002061040A3 Gene delivery formulations and methods for treatment of ischemic conditions
02/27/2003WO2002055555A3 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
02/27/2003WO2002036136A3 Compositions and methods for prolonging survival of chilled platelets
02/27/2003WO2002020028A3 Method and composition for enhancing vision
02/27/2003WO2002012290A8 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
02/27/2003WO2001098481A3 Renal regulatory elements and methods of use thereof
02/27/2003US20030040607 Hematopoietic cell E-selection/L-selectin ligand polypeptides and methods of use thereof
02/27/2003US20030040500 Replication incompetent herpes virus vectors
02/27/2003US20030040498 Contacting the tumor cell with a replicon such that the replicon is taken up into tumor cell and tumor cell is killed
02/27/2003US20030040475 Agents for improving lipid metabolism and reducing high blood pressure
02/27/2003US20030040465 Neuregulins as modulators of cellular communication
02/27/2003US20030040462 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance
02/27/2003US20030040113 Propagation of cell tissue in suspension; prepare solution of chondrocytes, expose to sponge matrix, solidify matrix, recover solid support
02/27/2003US20030040112 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture
02/27/2003US20030040111 Differentiated cells suitable for human therapy
02/27/2003US20030040110 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof
02/27/2003US20030040023 Isolation of neural stem cells using gangliosides and other surface markers
02/27/2003US20030039987 Defects in periaxin associated with myelinopathies
02/27/2003US20030039984 Sequences upstream of the CARP gene, vectors containing them and uses thereof
02/27/2003US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer
02/27/2003US20030039701 Mixture containing animal extract from deer antlers
02/27/2003US20030039700 Heating, combustion of shell
02/27/2003US20030039678 Xenograft bone matrix for orthopedic applications
02/27/2003US20030039666 Use of parasitic biological agents for prevention and control of autoimmune diseases
02/27/2003US20030039656 Modified reoviral therapy
02/27/2003US20030039650 Adminstering t-cells that have been isolated and expanded ex vivo from a patient with an immune imbalance back into the patient
02/27/2003US20030039642 Embryonic stem cells, clinical applications and methods for expanding in vitro
02/27/2003US20030039641 Cells expressing anti-fc receptor binding components
02/27/2003US20030039640 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
02/27/2003US20030039639 Isolated stromal cells for use in the treatment of diseases of the central nervous system
02/27/2003US20030039634 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
02/27/2003US20030039628 Treating cancer or viral diseases for enhancing T-cell proliferation by administering an effective amount compound that inhibits the production or release of intercellular reactive oxygen metabolites
02/27/2003CA2496542A1 Humanised baculovirus
02/27/2003CA2457632A1 Identification and isolation of somatic stem cells and uses thereof
02/27/2003CA2457321A1 Combinatorial methods for inducing cancer cell death
02/27/2003CA2457143A1 In situ immunization
02/27/2003CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
02/27/2003CA2456716A1 Tissue implants and methods for making and using same
02/27/2003CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals
02/27/2003CA2455827A1 Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan
02/27/2003CA2452160A1 Generation of multipotent central nervous system stem cells
02/26/2003EP1285961A1 Method of forming vertebrate pancreas in vitro
02/26/2003EP1285087A2 Enzymatic assays for screening anti-cancer agents
02/26/2003EP1285079A2 Modified bovine adenovirus having altered tropism
02/26/2003EP1285078A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
02/26/2003EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators
02/26/2003EP1285058A2 Fertilization of aged oocytes
02/26/2003EP1285057A1 Isolation of mesenchymal stem cells and use thereof
02/26/2003EP1284994A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1259